Agios Pharmaceuticals Inc (STU:8AP)
€ 42 2.6 (6.6%) Market Cap: 2.40 Bil Enterprise Value: 1.91 Bil PE Ratio: 0 PB Ratio: 3.45 GF Score: 41/100

Agios Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 09, 2020 / 01:50PM GMT
Release Date Price: €33.02 (-1.29%)
Mohit Bansal
Citigroup Inc., Research Division - Director and Analyst

Great. Thank you, everyone, for joining us today. So my name is Mohit Bansal, I'm one of the biotech analysts here at Citi. And I'm very happy to have today team Agios. So we have Jackie Fouse, the CEO of the company. We also have Kendra Adams, she's the VP, IR; and we also have Holly Manning, the Director of IR with the company. Thank you, Jackie, Kendra and Holly for joining us today.

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Thanks for having us, Mohit. Happy to be here.

Questions & Answers

Mohit Bansal
Citigroup Inc., Research Division - Director and Analyst

Great. So maybe just to start with, why don't we start with you giving us a brief overview of Agios. It has been -- I think it was 2018 biotech conference that morning because announced that you are you're joining Agios as a CEO, you did not join right there, but it has been a little less than 2 years now. So last year, you have had success with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot